Joseph D. Losek
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Joseph D. Losek has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Peter W. Glaeser
2 shared publicationsAmanda Price
Department of Pediatrics, Medical University of South Carolina, Charleston, South Carolina, United States
1 shared publicationBenjamin Jackson
Department of Pediatrics, Medical University of South Carolina, Charleston, South Carolina, United States
1 shared publicationBrett MacLean
Medical University of South Carolina, Charleston, SC, USA
1 shared publicationChristine Walsh-Kelly
From the Department of Pediatrics, Medical College of Wisconsin, Children's Hospital of Wisconsin, Milwaukee
1 shared publicationDavid R. White
1 shared publication
Latest Publications
- 30 July 2015
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 52 (1) , 80-84
Hyperglycaemic hyperosmolar syndrome in children: Patient characteristics, diagnostic delays and associated complications
Aims: The aim of this study was to describe the demographical and clinical characteristics, diagnostic difficulties, and morbidity and mortality in children with hyperglycaemic hyperosmolar syndrome (HHS).Methods: Retrospective cross‐section descriptive study of children (97% in four (67%) patients. Three (60%) of five patients seen as outpatients were misdiagnosed, two cases were seen twice before an accurate diagnosis of HHS was made. There was one (17%) death. Complications included three patients with acute renal failure, one patient with seizures, and one patient with rhabdomyolysis and compartment syndrome leading to below the knee amputation. Malignant hyperthermia and ventricular arrhythmias occurred in the patient who expired. Three of the five patients who had autoantibody tests had positive results and were diagnosed with type 1 diabetes mellitus.Conclusions: Characteristics of children with HSS are variable for age, gender and BMI‐for‐age percentile and not predominately limited to obese male adolescent African‐American. Delay in diagnosis is common and morbidity and mortality in paediatric HHS are significant. The subsequent diagnosis of patients presenting with HHS includes type 1 and 2 diabetes mellitus.
- 30 July 2015
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 52 (1) , 80-84
Hyperglycaemic hyperosmolar syndrome in children: Patient characteristics, diagnostic delays and associated complications
Aims: The aim of this study was to describe the demographical and clinical characteristics, diagnostic difficulties, and morbidity and mortality in children with hyperglycaemic hyperosmolar syndrome (HHS).Methods: Retrospective cross‐section descriptive study of children (97% in four (67%) patients. Three (60%) of five patients seen as outpatients were misdiagnosed, two cases were seen twice before an accurate diagnosis of HHS was made. There was one (17%) death. Complications included three patients with acute renal failure, one patient with seizures, and one patient with rhabdomyolysis and compartment syndrome leading to below the knee amputation. Malignant hyperthermia and ventricular arrhythmias occurred in the patient who expired. Three of the five patients who had autoantibody tests had positive results and were diagnosed with type 1 diabetes mellitus.Conclusions: Characteristics of children with HSS are variable for age, gender and BMI‐for‐age percentile and not predominately limited to obese male adolescent African‐American. Delay in diagnosis is common and morbidity and mortality in paediatric HHS are significant. The subsequent diagnosis of patients presenting with HHS includes type 1 and 2 diabetes mellitus.
- 28 January 2010
- Published by SAGE Publications in Clinical Pediatrics
- Vol. 49 (5) , 502-505
Anisocoria and Topical Carbamate Exposure: Illustrative Case Report
- 28 January 2010
- Published by SAGE Publications in Clinical Pediatrics
- Vol. 49 (5) , 502-505
Anisocoria and Topical Carbamate Exposure: Illustrative Case Report
- 1 June 2008
- Published by Wolters Kluwer Health in Pediatric Emergency Care
- Vol. 24 (6) , 370-373
Blunt Laryngeal Trauma in Children
Blunt neck trauma is not common in children, but these injuries can be potentially life-threatening. Presenting symptoms and signs of laryngeal injuries are often subtle, and poor outcomes in regard to voice and airway function are associated with delayed diagnosis. The purpose of this report was to present a pediatric case that illustrates the subtle symptoms and signs of a laryngeal laceration. In this case, the appearance of the laryngeal laceration was similar to the glottis, highlighting the importance of developing airway management guidelines for blunt laryngeal injuries in children.
- 1 June 2008
- Published by Wolters Kluwer Health in Pediatric Emergency Care
- Vol. 24 (6) , 370-373
Blunt Laryngeal Trauma in Children
Blunt neck trauma is not common in children, but these injuries can be potentially life-threatening. Presenting symptoms and signs of laryngeal injuries are often subtle, and poor outcomes in regard to voice and airway function are associated with delayed diagnosis. The purpose of this report was to present a pediatric case that illustrates the subtle symptoms and signs of a laryngeal laceration. In this case, the appearance of the laryngeal laceration was similar to the glottis, highlighting the importance of developing airway management guidelines for blunt laryngeal injuries in children.
- 1 May 2008
- Published by Wolters Kluwer Health in Pediatric Emergency Care
- Vol. 24 (5) , 294-299
Tracheal Intubation Practice and Maintaining Skill Competency
One of the most critical resuscitation skills in pediatric emergency medicine is establishing and maintaining a patent airway. This often requires tracheal intubation (TI). The purpose of this survey study was to determine the practice of TI in pediatric emergency departments (PEDs) and the methods used by PED medical directors to maintain TI competency among PED physicians. This is an observational survey study. Medical directors of PEDs were surveyed through e-mail (http://web-online-surveys.com). There were 20 survey questions: 4 yes/no and 16 multiple choice. Of the 108 PED medical directors who were surveyed, 61 (57%) completed the questionnaire. The mean number of TI per PED for 1 year was 63.7; SD, 79.3; median, 37; range, 3 to 400. The mean percentage of TI that were rapid sequence intubations was 76%; SD, 19.8%; median, 83%; range, 30% to 100%. The physician types most commonly performing TI on nontrauma versus trauma patients were as follows: pediatric emergency medicine, 50 (82%) versus 43 (70%); emergency medicine, 4 (7%) versus 4 (7%); and anesthesiology, 1 (2%) versus 4 (7%). The physician types most commonly consulted for difficult airway patients were: anesthesiology, 40 (66%); and pediatric critical care, 14 (23%). Alternative or rescue airway equipment/procedures available to PED were as follows: laryngeal mask airway (LMA), 50 (90%); needle cricothyroidotomy, 47 (77%); fiberoptic scope, 34 (56%); and tracheal tube introducer, 22 (36%). There were 38 (62%) PED medical directors who judged the number of TI opportunities to be inadequate to maintain TI competency among their physicians. The following activities reported as required for remedial training or to maintain TI competency were: pediatric advanced life support/advanced pediatric life support courses, 42 (69%); simulation training, 29 (48%); perform TI under the supervision of an anesthesiologist, 23 (38%); advance airway course, 21 (34%); and/or none, 1 (2%). Most PED TI for both nontrauma and trauma patients were performed by PED physicians. Most of these were rapid sequence intubations. The number of TI per PED had a large range. Most PED medical directors judged this number to be inadequate to maintain TI competency. Didactic activities to maintain TI skills were most common, but many other activities were used.
- 1 May 2008
- Published by Wolters Kluwer Health in Pediatric Emergency Care
- Vol. 24 (5) , 294-299
Tracheal Intubation Practice and Maintaining Skill Competency
One of the most critical resuscitation skills in pediatric emergency medicine is establishing and maintaining a patent airway. This often requires tracheal intubation (TI). The purpose of this survey study was to determine the practice of TI in pediatric emergency departments (PEDs) and the methods used by PED medical directors to maintain TI competency among PED physicians. This is an observational survey study. Medical directors of PEDs were surveyed through e-mail (http://web-online-surveys.com). There were 20 survey questions: 4 yes/no and 16 multiple choice. Of the 108 PED medical directors who were surveyed, 61 (57%) completed the questionnaire. The mean number of TI per PED for 1 year was 63.7; SD, 79.3; median, 37; range, 3 to 400. The mean percentage of TI that were rapid sequence intubations was 76%; SD, 19.8%; median, 83%; range, 30% to 100%. The physician types most commonly performing TI on nontrauma versus trauma patients were as follows: pediatric emergency medicine, 50 (82%) versus 43 (70%); emergency medicine, 4 (7%) versus 4 (7%); and anesthesiology, 1 (2%) versus 4 (7%). The physician types most commonly consulted for difficult airway patients were: anesthesiology, 40 (66%); and pediatric critical care, 14 (23%). Alternative or rescue airway equipment/procedures available to PED were as follows: laryngeal mask airway (LMA), 50 (90%); needle cricothyroidotomy, 47 (77%); fiberoptic scope, 34 (56%); and tracheal tube introducer, 22 (36%). There were 38 (62%) PED medical directors who judged the number of TI opportunities to be inadequate to maintain TI competency among their physicians. The following activities reported as required for remedial training or to maintain TI competency were: pediatric advanced life support/advanced pediatric life support courses, 42 (69%); simulation training, 29 (48%); perform TI under the supervision of an anesthesiologist, 23 (38%); advance airway course, 21 (34%); and/or none, 1 (2%). Most PED TI for both nontrauma and trauma patients were performed by PED physicians. Most of these were rapid sequence intubations. The number of TI per PED had a large range. Most PED medical directors judged this number to be inadequate to maintain TI competency. Didactic activities to maintain TI skills were most common, but many other activities were used.
- 1 February 2006
- Published by Wolters Kluwer Health in Pediatric Emergency Care
- Vol. 22 (2) , 100-103
Effects of Initial Pain Treatment on Sedation Recovery Time in Pediatric Emergency Care
Objective: The purpose of this study is to compare the sedation recovery times of children receiving ketamine/midazolam (K/M) versus K/M and initial pain treatment (morphine or meperidine) in pediatric emergency care. Methods: Study method was a retrospective cross-sectional study of children receiving K/M for procedural sedation analgesia in an urban children's hospital pediatric emergency department (ED). A uniform data collection form was completed for each child. Results: During an 18-month period, 116 children received K/M for procedural sedation analgesia in the ED. For this study, 80 children met inclusion criteria: 33 patients received K/M only; 32 received K/M and morphine, and 15 received K/M and meperidine. In comparing the K/M only group with the K/M morphine and K/M meperidine groups, the mean ketamine and midazolam doses (mg/kg) were not significantly different. In comparing the recovery times (minutes) for the K/M only group (29.7; SD, 15.7) with the K/M morphine (41.1; SD, 22.4) and K/M meperidine (50.1; SD, 24.9) groups, there was a significant difference for both comparisons (95% confidence interval for difference between 2 means, −20.9 to −1.76 and −32.2 to −8.4, respectively). Conclusion: Sedation (K/M) recovery time is significantly greater for children receiving initial pain treatment (morphine or meperidine). Children receiving meperidine had the longest recovery time. Considering this prolonged recovery time and the unique adverse effects of meperidine compared with morphine, we recommend meperidine not be used for initial ED pain treatment of children.
- 1 February 2006
- Published by Wolters Kluwer Health in Pediatric Emergency Care
- Vol. 22 (2) , 100-103
Effects of Initial Pain Treatment on Sedation Recovery Time in Pediatric Emergency Care
Objective: The purpose of this study is to compare the sedation recovery times of children receiving ketamine/midazolam (K/M) versus K/M and initial pain treatment (morphine or meperidine) in pediatric emergency care. Methods: Study method was a retrospective cross-sectional study of children receiving K/M for procedural sedation analgesia in an urban children's hospital pediatric emergency department (ED). A uniform data collection form was completed for each child. Results: During an 18-month period, 116 children received K/M for procedural sedation analgesia in the ED. For this study, 80 children met inclusion criteria: 33 patients received K/M only; 32 received K/M and morphine, and 15 received K/M and meperidine. In comparing the K/M only group with the K/M morphine and K/M meperidine groups, the mean ketamine and midazolam doses (mg/kg) were not significantly different. In comparing the recovery times (minutes) for the K/M only group (29.7; SD, 15.7) with the K/M morphine (41.1; SD, 22.4) and K/M meperidine (50.1; SD, 24.9) groups, there was a significant difference for both comparisons (95% confidence interval for difference between 2 means, −20.9 to −1.76 and −32.2 to −8.4, respectively). Conclusion: Sedation (K/M) recovery time is significantly greater for children receiving initial pain treatment (morphine or meperidine). Children receiving meperidine had the longest recovery time. Considering this prolonged recovery time and the unique adverse effects of meperidine compared with morphine, we recommend meperidine not be used for initial ED pain treatment of children.
- 1 September 2005
- Published by Wolters Kluwer Health in Pediatric Emergency Care
- Vol. 21 (9) , 578-581
Survey of Academic Pediatric Emergency Departments Regarding Use of Evaluation and Management Codes
The aims of the study were to determine the frequency at which each emergency medicine evaluation and management (E/M) code is used, to identify factors associated with their use by academic pediatric emergency departments (PEDs), and to compare PED E/M code utilization rates with rates reported by Centers for Medicare and Medicaid Services for general emergency departments (EDs). A 24-question survey was sent to 42 academic PED medical directors. Questions pertained to PED demographics, physician staff, records/documentation, billing education, and E/M coding data for 1 year. The general ED E/M code utilization rates were obtained from the published Centers for Medicare and Medicaid Services database. Descriptive statistics and odds ratios were used to report and compare the data. Twenty (48%) of the surveys were returned, and 9 (21%) completed the E/M coding data questions. From these 9 departments, the mean PED annual census was 46,065 (range, 23,531-92,910). The methods of PED medical record documentation were template (6), handwritten (2), and dictation/transcription (1). Charge documents were completed by the PED physician (3), professional service coders (4), and hospital coders (2). Coding/documentation in-services were provided to the physicians of 7 PEDs, and billing audits were performed in 5 PEDs. The total number of charges for the 9 PEDs was 325,129, 78.4% of the census. Multiple reasons were given for the discrepancy between census and charges. The percentage of each of the 5 levels of service billed was calculated for each of the 9 PEDs. The 2 lowest levels of service were used 38.3% of the time, whereas the 2 highest were used 19.2% of the time. The range for the highest level of service varied widely from 5.3% to 53.3%. Approximately 65% of E/M codes used by general EDs were for the 2 highest levels of service. The PED with the highest percentage of upper level charges (53.4%) was the only PED that used dictation/transcription for documentation. Although the response rate was low, and thus the validity of the results was limited, the findings may serve as a benchmark for E/M code utilization in PEDs. The large variation in use of the E/M codes among the PED in our study and the lower rate of using the highest E/M codes by the PEDs compared with the general EDs suggest potential opportunities for academic PEDs to improve billing practices.
- 1 September 2005
- Published by Wolters Kluwer Health in Pediatric Emergency Care
- Vol. 21 (9) , 578-581
Survey of Academic Pediatric Emergency Departments Regarding Use of Evaluation and Management Codes
The aims of the study were to determine the frequency at which each emergency medicine evaluation and management (E/M) code is used, to identify factors associated with their use by academic pediatric emergency departments (PEDs), and to compare PED E/M code utilization rates with rates reported by Centers for Medicare and Medicaid Services for general emergency departments (EDs). A 24-question survey was sent to 42 academic PED medical directors. Questions pertained to PED demographics, physician staff, records/documentation, billing education, and E/M coding data for 1 year. The general ED E/M code utilization rates were obtained from the published Centers for Medicare and Medicaid Services database. Descriptive statistics and odds ratios were used to report and compare the data. Twenty (48%) of the surveys were returned, and 9 (21%) completed the E/M coding data questions. From these 9 departments, the mean PED annual census was 46,065 (range, 23,531-92,910). The methods of PED medical record documentation were template (6), handwritten (2), and dictation/transcription (1). Charge documents were completed by the PED physician (3), professional service coders (4), and hospital coders (2). Coding/documentation in-services were provided to the physicians of 7 PEDs, and billing audits were performed in 5 PEDs. The total number of charges for the 9 PEDs was 325,129, 78.4% of the census. Multiple reasons were given for the discrepancy between census and charges. The percentage of each of the 5 levels of service billed was calculated for each of the 9 PEDs. The 2 lowest levels of service were used 38.3% of the time, whereas the 2 highest were used 19.2% of the time. The range for the highest level of service varied widely from 5.3% to 53.3%. Approximately 65% of E/M codes used by general EDs were for the 2 highest levels of service. The PED with the highest percentage of upper level charges (53.4%) was the only PED that used dictation/transcription for documentation. Although the response rate was low, and thus the validity of the results was limited, the findings may serve as a benchmark for E/M code utilization in PEDs. The large variation in use of the E/M codes among the PED in our study and the lower rate of using the highest E/M codes by the PEDs compared with the general EDs suggest potential opportunities for academic PEDs to improve billing practices.
- 1 December 2004
- Published by Wolters Kluwer Health in Pediatric Emergency Care
- Vol. 20 (12) , 852-854
Atopic Dermatitis and Treatment With Topical Immunomodulators
Emergency physicians, pediatricians, dermatologists, and nurse practitioners. After completion of the article, the reader should be able to: List the diagnostic criteria for atopic dermatitis. Discuss the role of topical immunomodulators in atopic dermatitis. Describe the potential adverse effects of tacrolimus and pimecrolimus. Atopic dermatitis (AD) is itchy inflamed skin that becomes excoriated and lichenified. Williams et al1 diagnostic criteria are an itchy skin condition (or parental report of scratching or rubbing in a child) and 3 or more of the following: History of involvement of the skin creases such as folds of elbows, behind the knees, fronts of ankles, or around the neck (including cheeks in children under 10 years). A personal history of asthma or hay fever (or history of atopic disease in a first-degree relative in children under 4 years). A history of general dry skin in the last year. Visible flexural eczema (or eczema involving the cheeks/forehead and outer limbs in children under 4 years). Onset under the age of 6 years (not used if child is under 4 years). AD affects 10% to 20% of children younger than 14 years.2 Eighty-five to 90% of cases manifest in the first 5 years of life.3 Seventy percent of cases start in the first year of life.4 AD can clear before adulthood, but the relapse rate is 33%.5 The incidence of AD is increasing in the industralized nations.6 AD often precedes or is associated with other atopic diseases including asthma, allergic rhinoconjunctivitis, food allergies, and anaphylactic reactions. AD is common among family members. It occurs in 10% of children if no parent has AD, 50% if one parent is affected, and 75% if both parents have AD.7 The disease is chronic with intermittent flares. Severe flares may present with oozing, crusting, or impetiginous skin lesions. As with other chronic conditions of childhood, AD affects not only a child's physical abilities, but also emotional and psychosocial development. In addition, the care of this chronic condition that can involve diet restrictions, medications, and frequent physician visits disrupts family activities and adds direct and indirect financial expenses to the family.8 The pathophysiology of AD is T cell-mediated. It is secondary to allergen-induced activation of cutaneous mast cells, release of cytokines from T cell lymphocytes and activation of eosinophils. The primary cytokines are the Th2 type interleukin-4, -5, and -13.9 Histamines do not play a role in the pathophysiology of AD.10 Conventional treatment of AD includes skin moisturizers (emollients) and limiting exposure to environmental triggers and irritants. Short courses of topical steroids are commonly prescribed for flareups. Long-term use or dependence on topical steroids is associated with both local and systemic adverse effects (ie, skin atrophy and suppression of the hypothalamic-pituitary-adrenal axis).11 For recalcitrant disease, systemic immunosuppressant drugs (methotrexate, cyclosporine, and azathioprine) are prescribed.10 These drugs require close monitoring for bone marrow suppression and liver toxicity. Systemic corticosteroids are also effective, but the benefits need to be balanced with the risks of adrenal suppression, retarded growth, osteopenia, and cataracts.12 To avoid the risks of adverse effects from these systemic immunosuppressant drugs, two topical immumodulators have been approved for treatment of AD. The topical immunomodulators are recommended as secondary therapy and include tacrolimus and primecrolimus. These are not to replace short courses of topical steroids. They are recommended for flareups unresponsive to short courses of topical steroids involving the face and groin where midpotency to high-potency steroids are to be avoided or in other skin areas where long-term use of a moderate potency steroid is needed.
- 1 December 2004
- Published by Wolters Kluwer Health in Pediatric Emergency Care
- Vol. 20 (12) , 852-854
Atopic Dermatitis and Treatment With Topical Immunomodulators
Emergency physicians, pediatricians, dermatologists, and nurse practitioners. After completion of the article, the reader should be able to: List the diagnostic criteria for atopic dermatitis. Discuss the role of topical immunomodulators in atopic dermatitis. Describe the potential adverse effects of tacrolimus and pimecrolimus. Atopic dermatitis (AD) is itchy inflamed skin that becomes excoriated and lichenified. Williams et al1 diagnostic criteria are an itchy skin condition (or parental report of scratching or rubbing in a child) and 3 or more of the following: History of involvement of the skin creases such as folds of elbows, behind the knees, fronts of ankles, or around the neck (including cheeks in children under 10 years). A personal history of asthma or hay fever (or history of atopic disease in a first-degree relative in children under 4 years). A history of general dry skin in the last year. Visible flexural eczema (or eczema involving the cheeks/forehead and outer limbs in children under 4 years). Onset under the age of 6 years (not used if child is under 4 years). AD affects 10% to 20% of children younger than 14 years.2 Eighty-five to 90% of cases manifest in the first 5 years of life.3 Seventy percent of cases start in the first year of life.4 AD can clear before adulthood, but the relapse rate is 33%.5 The incidence of AD is increasing in the industralized nations.6 AD often precedes or is associated with other atopic diseases including asthma, allergic rhinoconjunctivitis, food allergies, and anaphylactic reactions. AD is common among family members. It occurs in 10% of children if no parent has AD, 50% if one parent is affected, and 75% if both parents have AD.7 The disease is chronic with intermittent flares. Severe flares may present with oozing, crusting, or impetiginous skin lesions. As with other chronic conditions of childhood, AD affects not only a child's physical abilities, but also emotional and psychosocial development. In addition, the care of this chronic condition that can involve diet restrictions, medications, and frequent physician visits disrupts family activities and adds direct and indirect financial expenses to the family.8 The pathophysiology of AD is T cell-mediated. It is secondary to allergen-induced activation of cutaneous mast cells, release of cytokines from T cell lymphocytes and activation of eosinophils. The primary cytokines are the Th2 type interleukin-4, -5, and -13.9 Histamines do not play a role in the pathophysiology of AD.10 Conventional treatment of AD includes skin moisturizers (emollients) and limiting exposure to environmental triggers and irritants. Short courses of topical steroids are commonly prescribed for flareups. Long-term use or dependence on topical steroids is associated with both local and systemic adverse effects (ie, skin atrophy and suppression of the hypothalamic-pituitary-adrenal axis).11 For recalcitrant disease, systemic immunosuppressant drugs (methotrexate, cyclosporine, and azathioprine) are prescribed.10 These drugs require close monitoring for bone marrow suppression and liver toxicity. Systemic corticosteroids are also effective, but the benefits need to be balanced with the risks of adrenal suppression, retarded growth, osteopenia, and cataracts.12 To avoid the risks of adverse effects from these systemic immunosuppressant drugs, two topical immumodulators have been approved for treatment of AD. The topical immunomodulators are recommended as secondary therapy and include tacrolimus and primecrolimus. These are not to replace short courses of topical steroids. They are recommended for flareups unresponsive to short courses of topical steroids involving the face and groin where midpotency to high-potency steroids are to be avoided or in other skin areas where long-term use of a moderate potency steroid is needed.
- 1 March 1989
- Published by Wolters Kluwer Health in Pediatric Emergency Care
- Vol. 5 (1) , 1-4
Prehospital pediatric endotracheal intubation performance review
Pediatric prehospital care was reviewed over a one year period to determine success rate, causes of unsuccessful attempts, and complications of performing endotracheal intubation. The Milwaukee County Emergency Medicine Technician-Paramedics (EMT-Ps) responded to 1467 pediatric (<19 years of age) patient calls. This accounted for 11% of the patients who received EMT-P care during the study period. Of the 63 patients requiring pediatric endotracheal intubation, 49 (78%) were successfully intubated. Of the 42 pulseless nonbreathing (PNB) patients, 39 (93%) were successfully intubated. Of the 21 patients judged to be in impending respiratory failure, 10 (48%) were successfully intubated. Common difficulties in intubating the PNB patient included inability to visualize the glottis and cords secondary to mucus and/or vomitus, use of inappropriately small endotracheal tubes, and accidental extubation during transport. Difficulties in intubating impending respiratory failure patients included patient resistance and seizure activity. We recommend that the EMT-P training curriculum include a review of these difficulties and that prehospital pediatric endotracheal intubation performance be monitored and reviewed with the EMT-Ps.
- 1 March 1989
- Published by Wolters Kluwer Health in Pediatric Emergency Care
- Vol. 5 (1) , 1-4
Prehospital pediatric endotracheal intubation performance review
Pediatric prehospital care was reviewed over a one year period to determine success rate, causes of unsuccessful attempts, and complications of performing endotracheal intubation. The Milwaukee County Emergency Medicine Technician-Paramedics (EMT-Ps) responded to 1467 pediatric (<19 years of age) patient calls. This accounted for 11% of the patients who received EMT-P care during the study period. Of the 63 patients requiring pediatric endotracheal intubation, 49 (78%) were successfully intubated. Of the 42 pulseless nonbreathing (PNB) patients, 39 (93%) were successfully intubated. Of the 21 patients judged to be in impending respiratory failure, 10 (48%) were successfully intubated. Common difficulties in intubating the PNB patient included inability to visualize the glottis and cords secondary to mucus and/or vomitus, use of inappropriately small endotracheal tubes, and accidental extubation during transport. Difficulties in intubating impending respiratory failure patients included patient resistance and seizure activity. We recommend that the EMT-P training curriculum include a review of these difficulties and that prehospital pediatric endotracheal intubation performance be monitored and reviewed with the EMT-Ps.